Sfoglia per AUTORE
CAPPUZZO F
Collezione AOU Alessandria
Items : 2
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2021 Oct;22(10):1438-1447. doi: 10.1016/S1470-2045(21)00404-6. Epub 2021 Sep 6.
2021
AOU Alessandria
AOU Alessandria
Pinto C; Zucali PA; Pagano M; Grosso F; Pasello G; Garassino MC; Tiseo M; Soto Parra H; Grossi F; Cappuzzo F; de Marinis F; Pedrazzoli P; Bonomi M; Gianoncelli L; Perrino M; Santoro A; Zanelli F; Bonelli C; Maconi A; Frega S; Gervasi E; Boni L; Ceresoli GL;
Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study. in Cancers / Cancers (Basel). 2020 Oct 13;12(10):2948. doi: 10.3390/cancers12102948.
2020
AOU Alessandria
AOU Alessandria
Pagano M; Ceresoli LG; Zucali PA; Pasello G; Garassino M; Grosso F; Tiseo M; Soto Parra H; Zanelli F; Cappuzzo F; Grossi F; De Marinis F; Pedrazzoli P; Gnoni R; Bonelli C; Torricelli F; Ciarrocchi A; Normanno N; Pinto C;